πŸ‡ΊπŸ‡Έ FDA
Patent

US 7834041

Dual-acting antihypertensive agents

granted A61PA61P43/00A61P9/00

Quick answer

US patent 7834041 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P43/00, A61P9/00, A61P9/04, A61P9/12